OTX-14-002: Device Exposure Registry

首次发布于 2014 年 12 月 5 日

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

计划入组 850 人 · 首次发布于 2026 年 4 月 7 日

CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension

计划入组 19 人 · 首次发布于 2020 年 4 月 24 日

OTL-221

OTL-104

OTL-81

Orphan Therapeutics Accelerator Pioneers Novel Funding Model to Rescue Ultra-Rare Disease Treatments

Strategic Partnerships Transform Gene Therapy Manufacturing for Rare Diseases as Market Reaches $11.4 Billion

Phase 1 HELIOS Trial Shows Promise for OTX-TKI in Diabetic Retinopathy Treatment